Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2025

BUY
$1.58 - $14.42 $15,482 - $141,301
9,799 New
9,799 $17,000
Q2 2024

Oct 08, 2025

BUY
$11.86 - $15.93 $116,216 - $156,098
9,799 New
9,799 $141,000
Q2 2024

Jul 31, 2024

BUY
$11.86 - $15.93 $367 - $493
31 Added 0.32%
9,799 $142,000
Q1 2024

Oct 08, 2025

BUY
$14.15 - $19.75 $138,217 - $192,918
9,768 New
9,768 $162,000
Q1 2024

May 07, 2024

BUY
$14.15 - $19.75 $183 - $256
13 Added 0.13%
9,768 $162,000
Q4 2023

Oct 08, 2025

BUY
$10.35 - $17.11 $100,964 - $166,908
9,755 New
9,755 $156,000
Q4 2023

Feb 01, 2024

SELL
$10.35 - $17.11 $414 - $684
-40 Reduced 0.41%
9,755 $157,000
Q3 2023

Oct 08, 2025

BUY
$11.59 - $16.7 $113,524 - $163,576
9,795 New
9,795 $131,000
Q3 2023

Nov 07, 2023

BUY
$11.59 - $16.7 $950 - $1,369
82 Added 0.84%
9,795 $132,000
Q2 2023

Oct 08, 2025

BUY
$12.93 - $18.76 $125,589 - $182,215
9,713 New
9,713 $166,000
Q2 2023

Aug 07, 2023

SELL
$12.93 - $18.76 $36,010 - $52,246
-2,785 Reduced 22.28%
9,713 $167,000
Q1 2023

Oct 08, 2025

BUY
$14.73 - $18.18 $20,813 - $25,688
1,413 Added 12.75%
12,498 $206,000
Q1 2023

May 02, 2023

BUY
$14.73 - $18.18 $20,813 - $25,688
1,413 Added 12.75%
12,498 $207,000
Q4 2022

Oct 08, 2025

BUY
$13.52 - $21.46 $149,869 - $237,884
11,085 New
11,085 $185,000
Q4 2022

Jan 30, 2023

BUY
$13.52 - $21.46 $22,335 - $35,451
1,652 Added 17.51%
11,085 $185,000
Q3 2022

Nov 08, 2022

BUY
$10.5 - $22.01 $1,396 - $2,927
133 Added 1.43%
9,433 $161,000
Q2 2022

Aug 04, 2022

BUY
$8.7 - $20.18 $80,910 - $187,674
9,300 New
9,300 $102,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $69.9M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.